middle.news
How Island Pharmaceuticals Is Advancing Galidesivir Through FDA’s Animal Rule
8:36am on Thursday 4th of December, 2025 AEDT
•
Pharmaceuticals
Read Story
How Island Pharmaceuticals Is Advancing Galidesivir Through FDA’s Animal Rule
8:36am on Thursday 4th of December, 2025 AEDT
Key Points
Submission of responses to FDA guidance on Galidesivir development
FDA confirmed eligibility for Animal Rule and Priority Review voucher
Pending FDA feedback expected by 2 January 2026
Plans to commence Marburg virus study in Q1 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ILA
OPEN ARTICLE